Uganda has started recruiting women for a clinical trial of a long-lasting injectable pre-exposure prophylaxis (PrEP).
The study is part of large-scale trials of an anti-retroviral (ARV) drug that will also be conducted in six other African countries. They are Kenya, Malawi, Botswana, Zimbabwe, South Africa and Swaziland.
...
AllAfrica Subscription Content
You must be an allAfrica.com subscriber for full access to certain content.
You have selected an article from the AllAfrica archive, which requires a subscription. You can subscribe by visiting our subscription page. Or for more information about becoming a subscriber, you can read our subscription and contribution overview.
For information about our premium subscription services:
You can also freely access - without a subscription - hundreds of today's top Africa stories and thousands of recent news articles from our home page »
Already a subscriber? Sign in for full access to article